NCT02917733View on ClinicalTrials.gov

A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Healthy
Interventions
DRUG

LY3039478

Administered orally

Trial Locations (1)

53704

Covance Clinical Research Inc, Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02917733 - A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 in Healthy Participants | Biotech Hunter | Biotech Hunter